EMPLOYMENT AGREEMENTEmployment Agreement • March 28th, 2022 • BiondVax Pharmaceuticals Ltd. • Biological products, (no disgnostic substances)
THIS PERSONAL EMPLOYMENT AGREEMENT (the “Agreement”) is made this 20th day of January 2021 by and between BiondVax Pharmaceuticals Ltd. registry number 51343610, a company having its principal place of business at Jerusalem BioPark, 2nd Floor, Hadassah Ein Kerem Campus, Jerusalem, Israel (the “Company”) and Amir Reichman (I.D. 032241911) Boomgaardlaan 29,1560 Hoeilaart, Belgium (the “Employee”).
Research Collaboration Agreement by and between Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. a German non-profit research organization having its postal address at Hofgartenstr. 8, 80539 München, Germany represented for the purpose of...Research Collaboration Agreement • March 28th, 2022 • BiondVax Pharmaceuticals Ltd. • Biological products, (no disgnostic substances)
LICENSE AGREEMENT by and between Max-Planck-Innovation GmbH a German corporation having a principal place of business at Amalienstraße 33, 80799 München, Germany -hereinafter called “MI”- and Georg-August-Universität Göttingen Stiftung Öffentlichen...License Agreement • March 28th, 2022 • BiondVax Pharmaceuticals Ltd. • Biological products, (no disgnostic substances)
NOTE: All provisions regarding the aRCA in italics and brackets throughout this template shall be included if the Parties mutually agree on and enter into such aRCA (including, without limitation, agreement on project plan and project funding), and shall be deleted if the Parties do not agree on such aRCA.
